09:58 AM EST - BioVaxys Technology Corp : Announces that Co-Founder, President & Chief Operating Officer Kenneth Kovan will be presenting at the MedInvest Oncology Investor Conference held in New York City on December 14-15, 2022. In partnership with the National Foundation for Cancer Research, the MedInvest Oncology Investor Conference is the preeminent indication-specific investor conference. The attendees are active investors in the oncology space and oncology-focused companies seeking investment and partnering opportunities, and include leading life science and oncology venture capitalists, family offices, pharma executives, private and public cancer companies and foundations. The National Cancer Institute is this year's Conference Presenting Partner. BioVaxys Technology Corp
shares C.BIOV are trading -$0.02 at $0.16.
